Weinhardt; Klaus Kurt
Patent Applications and Registrations
Patent applications and USPTO patent grants for Weinhardt; Klaus Kurt.The latest application filed is for "arylamine-substituted quinazolinone compounds useful as alpha 1a/b adrenergic receptor antagonists".
- Weinhardt; Klaus Kurt - San Francisco CA
- Weinhardt; Klaus Kurt - Palo Alto CA
| Patent | Date |
|---|---|
| Arylamine-substituted quinazolinone compounds useful as alpha 1A/B adrenergic receptor antagonists App 20070265446 - Connolly; Terrence Joseph ; et al. | 2007-11-15 |
| Arylamine-substituted quinazolinone compounds useful as alpha 1A/B adrenergic receptor antagonists Grant 7,244,738 - Connolly , et al. July 17, 2 | 2007-07-17 |
| 5-Substituted quinazolinone compounds useful as alpha 1A/B adrenergic receptor antagonists App 20050124607 - Chin, Elbert ; et al. | 2005-06-09 |
| Arylamine-substituted quinazolinone compounds useful as alpha 1A/B adrenergic receptor antagonists App 20050038016 - Connolly, Terrence Joseph ; et al. | 2005-02-17 |
| Aryl pyrimidine derivatives and uses thereof Grant 5,958,934 - Berger , et al. September 28, 1 | 1999-09-28 |
| Aryl pyrimidine derivatives Grant 5,863,924 - Berger , et al. January 26, 1 | 1999-01-26 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 